Keynote review: Epithelial and endothelial barriers in human disease

Drug Discovery Today

Volumn 10, Issue 6, 2005, Pages 395-408

  Mullin, James M ^a   Agostino, Nicole ^a   Rendon Huerta, Erika ^b   Thornton, James J ^c  

^a LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c LANKENAU HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ELECTROLYTE;

ALLERGY; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM; CELL ORGANELLE; CELL TRANSPORT; CENTRAL NERVOUS SYSTEM; DIABETES MELLITUS; DIARRHEA; DISEASE COURSE; ELECTROLYTE BALANCE; ENDOTHELIUM; EPITHELIUM; EPITHELIUM CELL; EVOLUTION; GENE MUTATION; GENERAL ASPECTS OF DISEASE; GENETIC ANALYSIS; GENETIC DISORDER; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCHEMISTRY; INFLAMMATION; LIQUID; MALIGNANT NEOPLASTIC DISEASE; MEMBRANE; MEMBRANE TRANSPORT; METABOLIC DISORDER; MICROENVIRONMENT; MICROORGANISM; MOLECULAR BIOLOGY; MORBIDITY; NONHUMAN; ORGAN; PATHOGENESIS; PATHOPHYSIOLOGY; PERMEABILITY; REVIEW; STROMA; TIGHT JUNCTION; TRANSPORT KINETICS; TUMOR; VIRUS;

ANIMALS; BACTERIAL INFECTIONS; DIABETES MELLITUS; ENDOTHELIUM; EPITHELIUM; GENETIC DISEASES, INBORN; HOMEOSTASIS; HUMANS; INFLAMMATION; NEOPLASMS; TIGHT JUNCTIONS; VIRUS DISEASES;

EID: 16244421402     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(05)03379-9     Document Type: Review

References (207)

1. Jinguji Y., Ishikawa H. Electron microscopic observations on the maintenance of the tight junction during cell division in the epithelium of the mouse small intestine. Cell Struct. Funct. 17:1992;27-37
2. Soler A.P., et al. Effects of epidermal growth factor versus phorbol ester on kidney epithelial (LLC-PK1) tight junction permeability and cell division. Exp. Cell Res. 207:1993;398-406
3. Saladik D.T., et al. Cell division does not increase transepithelial permeability of LLC-PK1 cell sheets. Exp. Cell Res. 220:1995;446-455
4. Kojima T., et al. Occludin and claudin-1 concentrate in the midbody of immortalized mouse hepatocytes during cell division. J. Histochem. Cytochem. 49:2001;333-340
5. Madara J. Maintenance of the macromolecular barrier at cell extrusion sites in intestinal epithelium: physiological rearrangement of tight junctions. J. Membr. Biol. 116:1990;177-184
6. Florian P., et al. Single-cell epithelial defects close rapidly by an actinomyosin purse string mechanism with functional tight junctions. J. Physiol. 545:2002;485-499
7. Peralta Soler A., et al. Tissue remodeling during tumor necrosis factor-induced apoptosis in LLC-PK1 renal epithelial cells. Am. J. Physiol. 270:1996;F869-F879
8. Schulzke J.D., et al. Epithelial and subepithelial resistance of rat large intestine: segmental differences, effect of stripping, time course, and action of aldosterone. Pflugers Arch. 407:1986;632-637
9. Fromm M., et al. Epithelial and subepithelial contributions to transmural electrical resistance of intact rat jejunum, in vitro. Pflugers Arch. 405:1985;400-402
10. Groot J., et al. Analysis of the ouabain-induced increase in transepithelial electrical resistance in the goldfish intestinal mucosa. Pflugers Arch. 392:1981;67-71
11. Nagel W., et al. Cellular and paracellular conductance patterns in voltage-clamped frog skin. Prog. Clin. Biol. Res. 126:1983;221-231
12. Finn A., Reuss L. Effects of changes in the composition of the serosal solution on the electrical properties of the toad urinary bladder epithelium. J. Physiol. 250:1975;541-558
13. Dvorak A., Dickersin G. Crohn's disease: transmission electron microscopic studies. I. Barrier function. Possible changes related to alterations of cell coat, mucous coat, epithelial cells, and Paneth cells. Hum. Pathol. 11:(Suppl. 5):1980;561-571
14. Farhadi A., et al. Intestinal barrier: an interface between health and disease. J. Gastroenterol. Hepatol. 18:2003;479-497
15. Podolsky D.K. Mucosal immunity and inflammation. V. Innate mechanisms of mucosal defense and repair: the best offense is a good defense. Am. J. Physiol. 277:1999;G495-G499
16. Baumgart D., Dignass A. Intestinal barrier function. Curr. Opin. Clin. Nutr. Metab. Care. 5:2002;685-694
17. Schneeberger E.E., Lynch R.D. Structure, function, and regulation of cellular tight junctions. Am. J. Physiol. 262:1992;L647-L661
18. Anderson J., Van Itallie C.M. Tight Junctions: closing in on the seal. Curr. Biol. 9:1999;R922-R924
19. Tsukita S., Furuse M. The structure and function of claudins, cell adhesion molecules at tight junctions. Ann N Y Acad Sci. 915:2000;129-135
20. Gonzalez-Mariscal L., et al. Tight junction proteins. Prog. Biophys. Mol. Biol. 81:2003;1-44
21. Hopkins A.M., et al. Modulation of tight junction function by G protein-coupled events. Adv. Drug Deliv. Rev. 41:2000;329-340
22. Lacaz-Vieira F. Tight junction dynamics: oscillations and the role of protein kinase C. J. Membr. Biol. 178:2000;151-161
23. Clarke H., et al. Modification of tight junction function by protein kinase C isoforms. Adv. Drug Deliv. Rev. 41:2000;283-301
24. Kottra G., Vank C. The forskolin-induced opening of tight junctions in Xenopus gallbladder epithelium is mediated by protein kinase C. Cell Mol. Bio.l (Noisy-le-grand). 49:2003;33-43
25. Duffey M., et al. Regulation of epithelial tight junction permeability by cyclic AMP. Nature. 294:1981;451-453
26. Ma T.Y., et al. Mechanism of extracellular calcium regulation of intestinal epithelial tight junction permeability: role of cytoskeletal involvement. Microsc. Res. Tech. 51:2000;156-168
27. Hecht G., et al. Expression of the catalytic domain of myosin light chain kinase increases paracellular permeability. Am. J. Physiol. 271:1996;C1678-C1684
28. Turner J.R., et al. Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. Am. J. Physiol. 273:1997;C1378-C1385
29. Stuart R.O., et al. Critical role for intracellular calcium in tight junction biogenesis. J. Cell. Physiol. 159:1994;423-433
30. Gonzalez-Mariscal L., et al. Role of calcium in tight junction formation between epithelial cells. Am. J. Physiol. 259:1990;C978-C986
31. Siliciano J.D., Goodenough D.A. Localization of the tight junction protein, ZO-1, is modulated by extracellular calcium and cell-cell contact in Madin-Darby canine kidney epithelial cells. J. Cell Biol. 107:1988;2389-2399
32. Denker B.M., et al. Involvement of a heterotrimeric G protein alpha subunit in tight junction biogenesis. J. Biol. Chem. 271:1996;25750-25753
33. Hirase T., et al. Regulation of tight junction permeability and occludin phosphorylation by Rhoa-p160ROCK-dependent and -independent mechanisms. J. Biol. Chem. 276:2001;10423-10431
34. Jou T., et al. Structural and functional regulation of tight junctions by RhoA and Rac1 small GTPases. J. Cell Biol. 142:1998;101-115
35. Meyer T., et al. Zonula occludens-1 is a scaffolding protein for signaling molecules. Galpha(12) directly binds to the Src homology 3 domain and regulates paracellular permeability in epithelial cells. J. Biol. Chem. 277:2002;24855-24858
36. Rubenstein N.M., et al. Glucocorticoid down-regulation of RhoA is required for the steroid-induced organization of the junctional complex and tight junction formation in rat mammary epithelial tumor cells. J. Biol. Chem. 278:2003;10353-10360
37. Sawada N., et al. Tight junctions and human diseases. Med. Electron Microsc. 36:2003;147-156
38. McCarthy K.M., et al. Occludin is a functional component of the tight junction. J. Cell Sci. 109:1996;2287-2298
39. Holman G., Naftalin R. Fluid movements across rabbit ileum coupled to passive paracellular ion movements. J. Physiol. 290:1979;351-366
40. Fasano A., et al. Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc. Natl. Acad. Sci. U.S.A. 88:1991;5242-5246
41. Fasano A. Regulation of intercellular tight junctions by zonula occludens toxin and its eukaryotic analogue zonulin. Ann N Y Acad Sci. 915:2000;214-222
42. Balkovetz D., Katz J. Bacterial invasion by a paracellular route: divide and conquer. Microbes Infect. 5:2003;613-619
43. Berkes J., et al. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut. 52:2003;439-451
44. Clayburgh D., et al. A porous defense: the leaky epithelial barrier in intestinal disease. Lab. Invest. 84:2004;282-291
45. Hofman P. Pathological interactions of bacteria and toxins with the gastrointestinal epithelial tight junctions and/or the zonula adherens: an update. Cell Mol. Biol. (Noisy-le-grand). 49:2003;65-75
46. Sears C.L. Molecular physiology and pathophysiology of tight junctions V. assault of the tight junction by enteric pathogens. Am. J. Physiol. Gastrointest. Liver Physiol. 279:2000;G1129-G1134
47. Philpott D.J., et al. Signal transduction pathways involved in enterohemmorrhagic Escherichia coli-induced alterations in T84 epithelial permeability. Infect. Immun. 66:1998;1680-1687
48. Li Z., et al. Shiga toxin-producing Escherichia coli can impair T84 cell structure and function without inducing attaching/effacing lesions. Infect. Immun. 67:1999;5938-5945
49. Obiso R.J. Jr, et al. The Bacteroides fragilis toxin fragilysin disrupts the paracellular barrier of epithelial cells. Infect. Immun. 65:1997;1431-1439
50. Gogarten W., et al. Effect of acute Yersinia enterocolitica infection on intestinal barrier function in the mouse. Scand. J. Gastroenterol. 29:1994;814-819
51. Singh U., et al. CaCo-2 cells treated with Clostridium perfringens enterotoxin form multiple large complex species, one of which contains the tight junction protein occludin. J. Biol. Chem. 275:2000;18407-18417
52. Sonoda N., et al. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier. J. Cell Biol. 147:1999;195-204
53. Wu Z., et al. Distinct effects of Vibrio cholerae haemagglutinin/protease on the structure and localization of the tight junction-associated proteins occludin and ZO-1. Cell. Microbiol. 2:2000;11-17
54. Chen M., et al. Protein kinase C signaling regulates ZO-1 translocation and increased paracellular flux of T84 coloncytes exposed to Clostridium difficile toxin A. J. Biol. Chem. 277:2002;4247-4254
55. Nusrat A., et al. Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins. Infect. Immun. 69:2001;1329-1336
56. MacIntyre A., et al. Chlamydia pneumoniae infection alters the junctional complex proteins of human brain microvascular endothelial cells. FEMS Microbiol. Lett. 217:2002;167-172
57. Chen S., et al. Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J. Med. Microbiol. 52:2003;961-970
58. Terres A.M., et al. Helicobacter pylori disrupts epithelial barrier function in a process inhibited by protein kinase C activators. Infect. Immun. 66:1998;2943-2950
59. Suzuki K., et al. SS1 Helicobacter pylori disrupts the paracellular barrier of the gastric mucosa and leads to neutrophilic gastritis in mice. Virchows Arch. 440:2002;318-324
60. Papini E., et al. Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin. J. Clin. Invest. 102:1998;813-820
61. Dickman K.G., et al. Rotavirus alters paracellular permeability and energy metabolism in caco-2 cells. Am. J. Physiol. Gastrointest. Liver Physiol. 279:2000;G757-G766
62. Tafazoli F., et al. NSP4 enterotoxin of rotavirus induces paracellular leakage in polarized epithelial cells. J. Virol. 75:2001;1540-1546
63. Nava P., et al. The rotavirus surface protein VP8 modulates the gate and fence function of epithelial cells. J. Cell Sci. 117:2004;5509-5519
64. Madara J.L., Pappenheimer J.R. Structural basis for physiological regulation of paracellular pathways in intestinal epithelia. J. Membr. Biol. 100:1987;149-164
65. Adler J., et al. Chemotaxis toward sugars in Escherichia coli. J. Bacteriol. 115:1973;824-847
66. van der Drift C., et al. Chemotaxis of a motile Streptococcus toward sugars and amino acids. J. Bacteriol. 124:1975;1142-1147
67. Meggs W., et al. Nasal pathology and ultrastructure in patients with chronic airway inflammation (RADS and RUDS) following an irritant exposure. J. Toxicol. Clin. Toxicol. 34:1996;383-396
68. Wan H., et al. The transmembrane protein occludin of epithelial tight junctions is a functional target for serine peptidases from faecal pellets of Dermatophagoides pteronyssinus. Clin. Exp. Allergy. 31:2001;279-294
69. Wan H., et al. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin. Invest. 104:1999;123-133
70. Baker S., et al. Peptidase allergen Der p 1 initiates apoptosis of epithelial cells independently of tight junction proteolysis. Mol. Membr. Biol. 20:2003;71-81
71. Bates P., et al. Effect of cotton, hemp, and flax dust extracts on lung permeability in the guinea pig. Exp. Lung Res. 21:1995;643-665
72. Robinson C., et al. Peptidase allergens, occludin and claudins. Do their interactions facilitate the development of hypersensitivity reactions at mucosal surfaces? Clin. Exp. Allergy. 31:2001;186-192
73. Parkos C.A., et al. Neutrophil migration across a cultured epithelial monolayer elicits a biphasic resistance response representing sequential effects on transcellular and paracellular pathways. J. Cell Biol. 117:1992;757-764
74. Colgan S., et al. Neutrophil migration across cultured intestinal epithelial monolayers is modulated by epithelial exposure to IFN-gamma in a highly polarized fashion. J. Cell Biol. 120:1993;785-798
75. Huber D., et al. Occludin modulates transepithelial migration of neutrophils. J. Biol. Chem. 275:2000;5773-5778
76. Nash S., et al. The selective and superoxide-independent disruption of intestinal epithelial tight junctions during leukocyte transmigration. Lab. Invest. 59:1988;531-537
77. Burns A., et al. Analysis of tight junctions during neutrophil transendothelial migration. J. Cell Sci. 113:2000;45-57
78. Michail S.K., et al. Enteropathogenic Escherichia coli: stimulating neutrophil migration across a cultured intestinal epithelium without altering transepithelial conductance. J. Pediatr. Gastroenterol. Nutr. 36:2003;253-260
79. Edens H., et al. Neutrophil transepithelial migration: evidence for sequential, contact-dependent signaling events and enhanced paracellular permeability independent of transjunctional migration. J. Immunol. 169:2002;476-486
80. Mrsny R.J., et al. Identification of hepoxilin A3 in inflammatory events: a required role in neutrophil migration across intestinal epithelia. Proc. Natl. Acad. Sci. U.S.A. 101:2004;7421-7426
81. Burns A., et al. Neutrophil transendothelial migration is independent of tight junctions and occurs preferentially at tricellular corners. J. Immunol. 159:1997;2893-2903
82. Poritz L.S., et al. Tumor necrosis factor alpha disrupts tight junction assembly. J. Surg. Res. 116:2004;14-18
83. Lechner J., et al. Effects of interferon alpha-2b on barrier function and junctional complexes of renal proximal tubular LLC-PK1 cells. Kidney Int. 55:1999;2178-2191
84. Mullin J.M., et al. Different size limitations for increased transepithelial paracellular solute flux across phorbol ester and tumor necrosis factor-treated epithelial cell sheets. J. Cell. Physiol. 171:1997;226-233
85. Madara J.L., Stafford J. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J. Clin. Invest. 83:1989;724-727
86. Ma T., et al. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am. J. Physiol. Gastrointest. Liver Physiol. 286:2004;G367-G376
87. Adams R., et al. IFN-gamma modulation of epithelial barrier function. Time course, reversibilty, and site of cytokine binding. J. Immunol. 150:1993;2356-2363
88. Rodriguez P., et al. Tumour necrosis factor-alpha induces morphological and functional alterations of intestinal HT29 cl.19A cell monolayers. Cytokine. 7:1995;441-448
89. Madsen K., et al. Interleukin 10 prevents cytokine-induced disruption of T84 monolayer barrier integrity and limits chloride secretion. Gastroenterology. 113:1997;151-159
90. Schmitz H., et al. Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J. Cell Sci. 112:1999;137-146
91. Gitter A., et al. Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis. FASEB J. 14:2000;1749-1753
92. Bojarski C., et al. Apoptosis and intestinal barrier function. Ann N Y Acad Sci. 915:2000;270-274
93. Bojarski C., et al. Permeability of human HT-29/B6 colonic epithelium as a function of apoptosis. J. Physiol. 535:2001;541-552
94. Bojarski C., et al. The specific fates of tight junction proteins in apoptotic epithelial cells. J. Cell Sci. 117:2004;2097-2107
95. Gitter A., et al. Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology. 121:2001;1320-1328
96. Burgel N., et al. Mechanisms of diarrhea in collagenous colitis. Gastroenterology. 123:2002;433-443
97. Yoshida Y., et al. Altered expression of occludin and tight junction formation in psoriasis. Arch. Dermatol. Res. 293:2001;239-244
98. McDermott J., et al. Mast cells disrupt epithelial barrier function during enteric nematode infection. Proc. Natl. Acad. Sci. U.S.A. 100:2003;7761-7766
99. Huber J., et al. Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. Am. J. Physiol. Heart Circ. Physiol. 280:2001;H1241-H1248
100. Wolburg H., et al. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol. (Berl.). 105:2003;586-592
101. Hollander D. Crohn's disease-A permeability disorder of the tight junction. Gut. 29:1988;1621-1624
102. Gassler N., et al. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am. J. Physiol. Gastrointest. Liver Physiol. 281:2001;G216-G228
103. Kucharzik T., et al. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am. J. Pathol. 159:2001;2001-2009
104. Fries W., et al. Experimental colitis increases small intestine permeability in the rat. Lab. Invest. 79:1999;49-57
105. Barmeyer C., et al. Mechanisms of diarrhea in the interleukin-2-deficient mouse model of colonic inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 286:2004;G244-G252
106. Lee C., et al. Demonstration of the role of prostate-specific antigen in semen liquefaction by two-dimensional electrophoresis. J. Androl. 10:1989;432-438
107. Derubertis F., Craven P. Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes. 43:1994;1-8
108. Rossi F., et al. De novo synthesis of diacylglycerol from glucose. A new pathway of signal transduction in human neutrophils stimulated during phagocytosis of beta-glucan particles. J. Biol. Chem. 266:1991;8034-8038
109. Mullin J.M., O'Brien T.G. Effects of tumor promoters on LLC-PK1 renal epithelial tight junctions and transepithelial fluxes. Am. J. Physiol. 251:1986;C597-C602
110. Balda M.S., et al. Assembly and sealing of tight junctions: Possible participation of G-proteins, phospholipase C, protein kinase C and calmodulin. J. Membr. Biol. 122:1991;193-202
111. Tai Y.H., et al. Regulation of tight junction resistance in T84 monolayers by elevation in intracellular Ca2+: A protein kinase C effect. J. Membr. Biol. 149:1996;71-79
112. Mullin J.M., et al. Transepithelial paracellular leakiness induced by chronic phorbol ester exposure correlates with polyp-like foci and redistribution of protein kinase C-alpha. Carcinogenesis. 18:1997;2339-2345
113. Antcliff R., Marshall J. The pathogenesis of edema in diabetic maculopathy. Semin. Ophthalmol. 14:1999;223-232
114. Caldwell R., Slapnick S. Freeze-fracture and lanthanum studies of the retinal microvasculature in diabetic rats. Invest. Ophthalmol. Vis. Sci. 33:1992;1610-1619
115. Gardner T. Histamine, ZO-1 and increased blood-retinal barrier permeability in diabetic retinopathy. Trans. Am. Ophthalmol. Soc. 93:1995;583-621
116. Antonetti D., et al. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decrease occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes. 47:1998;19953-19959
117. Barber A., Antonetti D. Mapping the blood vessels with paracellular permeability in the retinas of diabetic rats. Invest. Ophthalmol. Vis. Sci. 44:2003;5410-5416
118. Antonetti D., et al. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J. Biol. Chem. 274:1999;23463-23467
119. Chehade J., et al. Diabetes-related changes in rat cerebral occludin and zonula occludens-1 (ZO-1) expression. Neurochem. Res. 27:2002;249-252
120. Babawale M., et al. Effects of gestational diabetes on junctional adhesion molecules in human term placental vasculature. Diabetologia. 43:2000;1185-1196
121. Strauli P., Haemmerli G. The role of cancer cell motility in invasion. Cancer Metastasis Rev. 3:1984;127-141
122. Carter S. Principles of cell motility: the direction of cell movement and cancer invasion. Nature. 208:1965;1183-1187
123. Martin T., et al. Hepatocyte growth factor disrupts tight junctions in human breast cancer cells. Cell Biol. Int. 28:2004;361-371
124. Tan X., et al. Analysis of invasion-metastasis mechanism in pancreatic cancer: involvement of tight junction transmembrane protein occludin and MEK/ERK signal transduction pathway in cancer cell dissociation. Oncol. Rep. 11:2004;993-998
125. Mullin J.M. Epithelial barriers, compartmentation, and cancer. Science STKE 2004. 2004;2
126. Martinez-Palomo A. Ultrastructural modifactions of intercellular junctions. In Vitro. 6:1970;15-20
127. Posalaky Z., McGinley D. Occluding junctions in an epithelioid mesothelioma: a freeze-fracture study. Ultrastruct. Pathol. 6:1984;177-183
128. Alroy J. Ultrastructure of canine urinary bladder carcinoma. Vet. Pathol. 16:1979;693-701
129. Robenek H., et al. Structure and function of the junctional complement of spontaneous and transplanted muring mammary carcinomas. J. Submicrosc. Cytol. 13:1981;347-363
130. Kerjaschki D., et al. The structure of tight junctions in human thyroid tumors. A systematic freeze-fracture study. Am. J. Pathol. 96:1979;207-225
131. Polak-Charcon S., et al. Tight junctions of epithelial cells of human fetal hindgut, normal colon and colon adenocarcinoma. J. Natl. Cancer Inst. 65:1980;53-57
132. Aoyagi K., et al. Morphological change in the MNNG-treated rat gastric mucosa. Kurume Med. J. 47:2000;31-36
133. Saito T. Ultrastructural changes on the junctional complexes in the human urinary bladder carcinoma by thin sectioning and freeze fracture. J Clin Electron Micros. 17:1984;201-209
134. Swift J.G., et al. Intercellular junctions in hepatocellular carcinoma. J. Submicrosc. Cytol. 15:1983;799-810
135. Davies R., et al. Detection of the cancer-prone colon, using transepithelial impedance analysis. Arch. Surg. 124:1989;480-484
136. Gonzalez-Correa C., et al. Low frequency electrical bioimpedance for the detection of inflammation and dysplasia in Barrett's. Physiol. Meas. 24:2003;291-296
137. Soderholm J.D., et al. Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease. Gut. 50:2002;307-313
138. Blanco D., et al. Altered expression of adhesion molecules and epithelial-mesenchymal transition in silica-induced rat lung carcinogenesis. Lab. Invest. 84:2004;999-1012
139. Liebner S., et al. Correlation of tight junction morphology with the expression of tight junction proteins in blood-brain barrier endothelial cells. Eur. J. Cell Biol. 79:2000;707-717
140. Soler A.P., et al. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis. 20:1999;1425-1431
141. Guan Y., et al. Transforming growth factor-alpha abrogates the glucocorticoid stimulation of tight junction formation and reverses the steroid-induced down-regulation of fascin in rat mammary epithelial tumor cells by a Ras-dependent pathway. Exp. Cell Res. 273:2002;1-11
142. Chen Y., et al. Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells. Mol. Biol. Cell. 11:2000;849-862
143. Nunbhakdi-Craig V., et al. Simian virus 40 small tumor antigen induces deregulation of the actin cytoskeleton and tight junctions in kidney epithelial cells. J. Virol. 77:2003;2807-2818
144. Jiang W., et al. Hepatocyte growth factor/scatter factor decreases the expression of occluding and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells. J. Cell. Physiol. 181:1999;319-329
145. Resnick, M.B. et al. Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod. Pathol. (in press)
146. Tobioka H., Sawada N. Occludin expression decreases with the progression of human endometrial carcinoma. Hum. Pathol. 35:2004;159-164
147. Tobioka H., et al. Polarized distribution of carcinoembryonic antigen is associated with a tight junction molecule in human colorectal adenocarcinoma. J. Pathol. 198:2002;207-212
148. Busch C., et al. Down-regulation of CEACAM1 in human prostate cancer: correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition. Hum. Pathol. 33:2002;290-298
149. Kimura Y., et al. Expression of occludin, tight-junction-associated protein, in human digestive tract. Am. J. Pathol. 151:1997;45-54
150. Marzioni D., et al. Expression of ZO-1 and occludin in normal human placenta and in hydatidiform moles. Mol. Hum. Reprod. 7:2001;279-285
151. Davies R. Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J. Anat. 200:2002;639-646
152. Papadopoulos M.C., et al. Occludin expression in microvessels of neoplastic and non-neoplastic human brain. Neuropathol. Appl. Neurobiol. 27:2001;384-395
153. Wang W., et al. VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am. J. Physiol. Heart Circ. Physiol. 280:2001;H434-H440
154. Kramer F., et al. Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer. Hum. Genet. 107:2000;249-256
155. Willott E., et al. The tight junction protein ZO-1 is homologous to the Drosophila discs-large tumor suppressor protein of septate junctions. Proc. Natl. Acad. Sci. U.S.A. 90:1993;7834-7838
156. Miwa N., et al. Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol. Res. 12:2000;469-476
157. Folpe A., et al. Expression of claudin-1, a recently described tight junction-associated protein, distinguishes soft tissue perineurioma from potential mimics. Am. J. Surg. Pathol. 26:2002;1620-1626
158. Kominsky S.L., et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene. 22:2003;2021-2033
159. Rangel L.B., et al. Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin. Cancer Res. 9:2003;2567-2575
160. Rangel L.B., et al. Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression. Oncogene. 22:2003;7225-7232
161. Zheng J.Y., et al. Regulation of the expression of the prostate-specific antigen by claudin-7. J. Membr. Biol. 194:2003;187-197
162. Fanning A., et al. Transmembrane proteins in the tight junction barrier. J. Am. Soc. Nephrol. 10:1999;1337-1345
163. Tsukita S., Furuse M. Occludin and claudins in tight-junction strands:leading or supporting players? Cell Biology. 9:1999;268-273
164. Furuse M., et al. Occludin: A novel integral membrane protein localizing at tight junctions. J. Cell Biol. 123:1993;1777-1788
165. Martin-Padura I., et al. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that contributes at intercellular junctions and modulates monocyte transmigration. J. Cell Biol. 142:1998;117-127
166. Cunningham S., et al. A novel protein with homology to the junctional adhesion molecule. Characterization of leukocyte interactions. J. Biol. Chem. 275:2000;34750-34756
167. Cohen C., et al. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc. Natl. Acad. Sci. U.S.A. 98:2001;15191-15196
168. Nasdala I., et al. A transmembrane tight junction protein selectively expressed on endothelial cells and platelets. J. Biol. Chem. 277:2002;16294-16303
169. Furuse M., et al. Claudin-1 and -2: Novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J. Cell Biol. 141:1998;1539-1550
170. Tsukita S., Furuse M. Pores in the wall: claudins constitute tight junction strands containing aqueous pores. J. Cell Biol. 149:2000;13-16
171. Shareghi G.R., Agus Z.S. Magnesium transport in the cortical thick ascending limb of Henle's loop of the rabbit. J. Clin. Invest. 69:1982;759-769
172. Quamme G.A., Dirks J.H. Magnesium transport in the nephron. Am. J. Physiol. 239:1980;F393-F401
173. Praga M., et al. Familial hypomagnesemia with hypercalcinuria and nephrocalcinosis. Kidney Int. 47:1995;1419-1425
174. Simon D.B., et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science. 285:1999;103-106
175. Hirano T., et al. Null mutation of PCLN-1/Claudin-16 results in bovine interstitial nephritis. Genome Res. 10:2000;659-663
176. Muller D., et al. A novel claudin 16 mutation associated with childhood hypercalciuria abolishes binding to ZO-1 and results in lysosomal mistargeting. Am. J. Hum. Genet. 73:2003;1293-1301
177. Wilcox E.R., et al. Mutations in the gene encoding tight junction claudin-14 cause autosomal recessive deafness DFNB29. Cell. 104:2001;165-172
178. Johnstone B., Sellick P. The peripheral auditory apparatus. Q. Rev. Biophys. 5:1972;1-75
179. Gratton M., et al. Decline in the endocochlear potential corresponds to decreased Na, K-ATPase activity in the lateral wall of quiet-aged gerbils. Hear. Res. 108:1997;9-16
180. Shapiro B.L. The Down syndrome critical region. J. Neural Transm. Suppl. 57:1999;41-60
181. Gow A., et al. CNS Myelin and sertoli cell tight junction strands are absent in Osp/Claudin-11 null mice. Cell. 99:1999;649-659
182. Gow A., et al. Deafness in Claudin 11-null mice reveals the critical contribution of basal cell tight junctions to stria vascularis function. J. Neurosci. 24:2004;7051-7062
183. Yamauchi K., et al. Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins. Proc. Natl. Acad. Sci. U.S.A. 101:2004;4690-4694
184. Dallasta L., et al. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 155:1999;1915-1927
185. Schmitz H., et al. Supernatants of HIV-infected immune cells affect the barrier function of human HT-29/B6 intestinal epithelial cells. AIDS. 16:2002;983-991
186. Schulzke J.D., et al. Epithelial tight junction structure in the jejunum of children with acute and treated celiac sprue. Pediatr. Res. 43:1998;435-441
187. Vogelsang H., et al. Changes in gastrointestinal permeability in celiac disease. Dig. Dis. 16:1998;333-336
188. Schmitt M., et al. Disruption of paracellular sealing is an early event in acute caerulein-pancreatitis. Pancreas. 28:2004;181-190
189. Takaya J., et al. Menetrier's disease evaluated serially by abdominal ultrasonography. Pediatr. Radiol. 27:1997;178-180
190. Oderda G., et al. Increased tight junction width in two children with Menetrier's disease. J. Pediatr. Gastroenterol. Nutr. 11:1990;123-127
191. Minagar A., et al. Serum from patients with multiple sclerosis downregulates occludin and VE-cadherin expression in cultured endothelial cells. Mult. Scler. 9:2003;235-238
192. Plumb J., et al. Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol. 12:2002;154-169
193. Keefe D.M., et al. Effect of high-dose chemotherapy on intestinal permeability in humans. Clin. Sci. (Lond.). 92:1997;385-389
194. Stelwagen K., et al. Short communication: effects of isolation stress on mammary tight junctions in lactating dairy cows. J. Dairy Sci. 83:2000;48-51
195. Mooradian A.D., et al. Age-related changes in rat cerebral occludin and zonula occludens-1 (ZO-1). Mech. Ageing Dev. 124:2003;143-146
196. Hollander D., Tarnawski H. Aging-associated increase in intestinal absorption of macromolecules. Gerontology. 31:1985;133-137
197. Katz D., et al. Aging-associated increase in intestinal permeability to polyethylene glycol 900. Dig. Dis. Sci. 32:1987;285-288
198. Johnson L., et al. Safety and efficiency of modulating paracellular permeability to enhance airway epithelial gene transfer in vivo. Hum. Gene Ther. 14:2003;729-747
199. Chen M., et al. Apical and basolateral EGF receptors regulate gastric mucosal paracellular permeability. Am. J. Physiol. Gastrointest. Liver Physiol. 280:2001;G264-G272
200. Singh A.B., Harris R.C. Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells. J. Biol. Chem. 279:2004;3543-3552
201. Antonetti D., et al. Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin. J. Neurochem. 80:2002;667-677
202. Zettl K.S., et al. Glucocorticoid-induced formation of tight junctions in mouse mammary epithelial cells in vitro. Proc. Natl. Acad. Sci. U.S.A. 89:1992;9069-9073
203. Naishiro Y., et al. Restoration of epithelial cell polarity in a colorectal cancer cell line by suppression of beta-catenin/T-cell factor 4-mediated gene transactivation. Cancer Res. 61:2001;2751-2758
204. Nakajima M., et al. WF-536 inhibits metastatic invasion by enhancing the host cell barrier and inhibiting tumour cell motility. Clin. Exp. Pharmacol. Physiol. 30:2003;457-463
205. Resta-Lenert S., Barrett K.E. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut. 52:2003;988-997
206. Michail S., Abernathy F. Lactobacillus plantarum inhibits the intestinal epithelial migration of neutrophils induced by enteropathogenic Escherichia coli. J. Pediatr. Gastroenterol. Nutr. 36:2003;385-391
207. Otte J.M., Podolsky D.K. Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am. J. Physiol. Gastrointest. Liver Physiol. 286:2004;G613-G626